Toll Free: 1-888-928-9744

Hawaii Biotech, Inc. - Product Pipeline Review - 2014

Published: Aug, 2014 | Pages: 31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Hawaii Biotech, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Hawaii Biotech, Inc. - Product Pipeline Review - 2014', provides an overview of the Hawaii Biotech, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Hawaii Biotech, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Hawaii Biotech, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Hawaii Biotech, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Hawaii Biotech, Inc.'s pipeline products

Reasons to buy

- Evaluate Hawaii Biotech, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Hawaii Biotech, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Hawaii Biotech, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Hawaii Biotech, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hawaii Biotech, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Hawaii Biotech, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Hawaii Biotech, Inc. Snapshot 5
Hawaii Biotech, Inc. Overview 5
Key Information 5
Key Facts 5
Hawaii Biotech, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Hawaii Biotech, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Hawaii Biotech, Inc. - Pipeline Products Glance 10
Hawaii Biotech, Inc. - Clinical Stage Pipeline Products 10
Phase I Products/Combination Treatment Modalities 10
Hawaii Biotech, Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Hawaii Biotech, Inc. - Drug Profiles 13
HBV-002 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
hepatitis C vaccine 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
malaria vaccine 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Small Molecules for Botulism 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecules to Inhibit Lethal Factor for Anthrax 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
tick-borne vaccine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
crimean-congo hemorrhagic fever vaccine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
influenza vaccine 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Hawaii Biotech, Inc. - Pipeline Analysis 23
Hawaii Biotech, Inc. - Pipeline Products by Target 23
Hawaii Biotech, Inc. - Pipeline Products by Route of Administration 24
Hawaii Biotech, Inc. - Pipeline Products by Molecule Type 25
Hawaii Biotech, Inc. - Pipeline Products by Mechanism of Action 26
Hawaii Biotech, Inc. - Recent Pipeline Updates 27
Hawaii Biotech, Inc. - Dormant Projects 28
Hawaii Biotech, Inc. - Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31
List of Tables
Hawaii Biotech, Inc., Key Information 5
Hawaii Biotech, Inc., Key Facts 5
Hawaii Biotech, Inc. - Pipeline by Indication, 2014 7
Hawaii Biotech, Inc. - Pipeline by Stage of Development, 2014 8
Hawaii Biotech, Inc. - Monotherapy Products in Pipeline, 2014 9
Hawaii Biotech, Inc. - Phase I, 2014 10
Hawaii Biotech, Inc. - Preclinical, 2014 11
Hawaii Biotech, Inc. - Discovery, 2014 12
Hawaii Biotech, Inc. - Pipeline by Target, 2014 23
Hawaii Biotech, Inc. - Pipeline by Route of Administration, 2014 24
Hawaii Biotech, Inc. - Pipeline by Molecule Type, 2014 25
Hawaii Biotech, Inc. - Pipeline Products by Mechanism of Action, 2014 26
Hawaii Biotech, Inc. - Recent Pipeline Updates, 2014 27
Hawaii Biotech, Inc. - Dormant Developmental Projects,2014 28
Hawaii Biotech, Inc., Other Locations 29 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify